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Q	 fever,	 caused	by	Coxiella burnetii, is a recognized 
occupational infection in persons who have regular contact 
with ruminants. We determined C. burnetii seroprevalence 
in residents living or working on dairy cattle farms with >50	
adult	cows	and	identified	risk	factors	for	seropositivity.	Se-
rum samples from farm residents, including employees, 
were tested for C. burnetii	 IgG	 and	 IgM;	 seroprevalence	
was	72.1%	overall	and	87.2%,	54.5%,	and	44.2%	among	
farmers,	 spouses,	 and	 children,	 respectively.	Risk	 factors	
included farm location in southern region, larger herd size, 
farm employment, birds in stable, contact with pigs, and in-
direct	contact	with	rats	or	mice.	Protective	factors	included	
automatic milking of cows and fully compliant use of gloves 
during and around calving. We recommend strengthening 
general biosecurity measures, such as consistent use of 
personal	protective	equipment	(e.g.,	boots,	clothing,	gloves)	
by farm staff and avoidance of birds and vermin in stables.
Q fever is an occupational zoonosis caused by Coxiella burnetii, a gram-negative bacterium (1). Ruminant 
farmers, laboratory workers, dairy workers, and veterinar-
ians are at particular risk for infection. Humans usually ac-
quire Q fever by inhalation of C. burnetii aerosolized from 
contaminated materials originating from infected animals. 
The primary animal reservoirs responsible for human in-
fections are cattle, sheep, and goats, which can shed C. 
burnetii in urine, feces, milk, and birth products. Before 
2007, the seroprevalence of C. burnetii antibodies within 
the general population of the Netherlands was 2.4%; keep-
ing ruminants and increasing age were risk factors for se-
ropositivity (2). During 2007–2009, Q fever was a major 
public health problem in the Netherlands; >4,000 human 
cases were reported (3). Large-scale interventions primar-
ily targeting small ruminants were used to control the epi-
demic. In 2008, mandatory vaccination was conducted in a 
defined cluster area and later nationwide. In 2009–2010, a 
program was implemented to cull pregnant dairy goats and 
sheep on farms with C. burnetii–positive animals identi-
fied through a national bulk tank milk (BTM) screening (4). 
Since then, the incidence of acute Q fever cases has dimin-
ished substantially (5), but chronic cases still occur (6). No 
epidemiologic associations between Q fever cases in hu-
mans and dairy cattle were identified during this epidemic, 
nor have any been described in other Q fever outbreaks 
(7). Nevertheless, recent reports indicate that C. burnetii 
is widespread among Dutch dairy cattle herds (prevalence 
78.6% [ELISA] or 56.6% [PCR] in BTM samples) (8). 
In 2008, seroprevalence was 16.0% in lactating cows and 
1.0% in young animals (8).
C. burnetii seroprevalence estimates for dairy cattle 
farm residents in the Netherlands are outdated, and risk 
factors associated with seropositivity are seldom studied. 
This lack of data inhibits accurate assessment of the public 
health risk. To inform control measures and provide advice 
for persons living/working on a dairy cattle farm (DCF), 
we conducted a cross-sectional study to investigate the se-
roprevalence of C. burnetii antibodies in DCF residents/
workers and identified participant-based and farm-based 
risk factors for seropositivity. The study was approved by 
the Medical Ethics Committee of the University Medical 
Centre Utrecht (no. 09–189/K).
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Methods
A total of 3,000 DCFs housing >50 adult dairy cows 
were randomly selected for possible participation in the 
study from a national database maintained by the Animal 
Health Service. In September and November 2010, infor-
mation and recruitment materials were sent to 1,000 and 
2,000 farms, respectively. Farms were enrolled in the study 
after returning a completed informed-consent form. After 
4 weeks, nonresponding farms from the first mailing re-
ceived a written reminder. Nonresponding farms from the 
second mailing did not receive a reminder because the 
goal of enrolling 296 farms had been reached; this number 
was determined on the basis of power calculations assum-
ing 50.0% prevalence and 5.5% precision. We contacted 
enrolled farms by telephone to confirm participation and 
determine the number of participants. Dairy cattle farmers 
and up to 2 family members or farm employees >12 years 
of age were eligible for participation in the study. Partici-
pants completed a questionnaire about personal character-
istics (e.g., age, medical history, farm-related activities, 
contact with livestock and companion animals, consump-
tion of unpasteurized dairy products, and use of personal 
protective equipment [PPE]) and provided a serum sample 
(collected by a laboratory assistant during a home visit). 
The farm owner or manager completed a questionnaire 
about herd size, cattle housing, presence of other livestock 
and companion animals, farm facilities, animal health, and 
hygiene measures. Participating farms were requested to 
provide one BTM sample for testing by ELISA and PCR, 
as described (8).
Serology
We used an immunofluorescence assay (IFA) (Focus 
Diagnostics, Cypress, CA, USA) to test serum samples for 
C. burnetii phase I and II IgM and IgG. All samples were 
screened at an initial dilution of 1:32; those with negative 
results were considered negative. Positive samples were 
further classified as indicative of relatively recent infec-
tions (IgM phase II titer >32) or past infections (IgG phase 
II titer >32 and IgM phase II titer <32). Samples with all 
other outcomes were considered negative. The term rela-
tively recent was chosen because phase II IgM is common-
ly found up to 1 year after infection in acute Q fever cases, 
but it may persist up to 3 years (9). Phase I and II IgG end 
point titers were determined for all seropositive persons. In 
agreement with chronic Q fever diagnostic criteria used in 
the Netherlands (10), phase I IgG titers ≥1,024 in samples 
in the past infection group were considered indicative of 
possible chronic infection.
Data Analysis
Participating and nonparticipating farms were 
compared with respect to herd size; distance to nearest 
C. burnetii–positive BTM small-ruminant farm; goat, 
sheep, and cattle density; location by province and region; 
and degree of urbanization. We used the Mann-Whitney U 
test to determine differences in continuous variables and 
the χ2 test to analyze categorical variables. We performed 
univariate logistic regression analyses to determine the 
main factors associated with C. burnetii seropositivity 
among participants (p<0.20, likelihood ratio test). Poten-
tial farm-based risk factors were analyzed by univariate 
multilevel analyses; a unique farm identifier was used as 
the cluster variable. Distributions of continuous variables 
were studied, and variables not linearly related to the out-
come variable were categorized on the basis of biological 
arguments (e.g., nearest C. burnetii–positive BTM small-
ruminant farm) or, if those were lacking, on medians (e.g., 
goat density within 5-km radius). Participant age was al-
ways kept in the model because of its frequent relation 
with seropositivity. Variables with <10.0% of participants 
in a risk category were excluded from further analysis. If 
several variables were found interrelated in the univariate 
analysis, only the most informative and relevant variable 
was selected for inclusion.
Risk factors determined to be significant (p<0.20) 
in univariate analyses of the participant-based and farm-
based data were incorporated into multivariate logistic 
regression and multivariate multilevel analyses, respec-
tively. Stratified multivariate analyses for participant risk 
factors were performed separately for farmers and for 
the remaining group. Starting with a full model, manual 
backward elimination was performed; all variables meet-
ing the 10.0% significance level in the likelihood ratio test 
were kept in the final model. Two-way interactions be-
tween biologically plausible variables in the multivariate 
model were investigated. Last, variables included in the 
final multivariate model for participant-based factors and 
those included in the multilevel model for farm-based fac-
tors were combined in a multivariate multilevel analysis 
to identify the independent risk determinants for seroposi-
tivity. The final model fit was assessed by the quasi-likeli-
hood under the independence model criterion goodness-of 
-fit statistic for generalized estimation equation models. 
SAS version 9.2 (SAS Institute, Cary, NC, USA) was 
used for all analyses.
Results
Nonresponse Analysis
Of the 3,000 invited farms, 311 provided a BTM 
sample, and 755 persons from 309 (10.3%) farms par-
ticipated in this study by providing a serum sample. A 
farm-based questionnaire was available for 736 (97.5%) 
persons from 301 farms, and a participant-based question-
naire was completed by 729 (96.6%) persons from 308 
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farms. Compared with nonparticipating farms, participat-
ing farms were a median of 1.5 km closer to small rumi-
nant farms with C. burnetii–positive BTM samples (Table 
1). In addition, the density of sheep within a 5-km radius 
of participating farms was higher than that for nonpartici-
pating farms; however, the absolute difference was very 
small (3 sheep/km2).
Seroprevalence
Overall C. burnetii seroprevalence was 72.1% (95% 
CI 68.8%–75.3%), and seroprevalence among farmers, 
spouses, and children (12–17 years of age) was 87.2%, 
54.5%, and 44.2%, respectively (Table 2). Seroprevalence 
was univariately significantly higher among male partici-
pants, farmers, and participants >35 years of age (Table 3, 
Appendix, wwwnc.cdc.gov/EID/article/20/3/13-1111-T3.
htm). The median duration of farm residence was 28 years 
(range 0–56). IgG phase II end titers were known for 534 
(98.9%) of 540 C. burnetii IgG phase II–seropositive par-
ticipants: 32 (n =166), 64 (n = 92), 128 (n = 119), 256 (n 
= 106), 512 (n = 39), 1,024 (n = 10), 2,048 (n = 1), and 
4,096 (n = 1). IgG phase I end titers were known for 283 
(97.6%) of the 290 IgG phase I–seropositive participants: 
32 (n = 105), 64 (n = 73), 128 (n = 61), 256 (n = 32), 512 
(n = 10), 1,024 (n = 1), and 2,048 (n = 1). These last 2 
participants, with phase I titers of 1,024 and 2,048, re-
spectively, had lower IgG phase II titers (512 and 1,024, 
respectively), and according to chronic Q fever diagnostic 
criteria used in the Netherlands (10), these participants 
met the conditions for possible chronic Q fever infec-
tion. We could not confirm that these truly were chronic 
Q fever cases because clinical information (e.g., presence 
of vascular infection, endocardial involvement, or other 
clinical risk factors) was lacking.
Nine (1.2%) participants from 8 farms were classified 
as having a relatively recent infection (IgM phase II titer 
range 32–256). All 8 farms were within 2.5–21.2 km of 
the nearest C. burnetii–positive BTM small-ruminant farm, 
and 4 of the 8 were within 3 km.
Four participants reported having had Q fever diag-
nosed by a physician during 2008–2010. On the basis of 
serum samples obtained at study entry, 3 of these par-
ticipants had a serologic profile indicating past infection. 
These 3 participants lived in the southern or eastern re-
gion of the Netherlands on farms within a 3-km radius 
of the nearest small-ruminant farm with C. burnetii–posi-
tive BTM samples. The fourth participant had no sero-
logic evidence of a past infection and lived 14 km from 
the nearest small-ruminant farm with C. burnetii–positive 
BTM samples.
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Table	1.	Nonresponse	analyses	of	farms	in	a	study	of	Coxiella burnetii seroprevalence and risk for seropositivity in humans on dairy 
cattle	farms,	the	Netherlands,	September	2010–March	2011 
Variable 
Farms 
p value Participating,	n	=	311 Nonparticipating,	n	=	2,685 
Categorical,	no.	(%)    
 Farm located inside vaccination area 83	(26.4) 590	(21.9) 0.08 
 Farm region*   0.36 
  North 80	(25.4) 781	(29.1)  
  East 104	(33.7) 911	(33.9)  
  West 57	(18.7) 494	(18.3)  
  South 70	(22.2) 503	(18.7)  
 Degree of urbanization of the farm municipality   0.77 
  Moderately,	strongly,	or	extremely	(>1,000	addresses/km2) 1	(0.3) 17	(0.6)  
  Hardly	(500–1,000	addresses/km2) 10	(3.2) 94	(3.5)  
  Not	(<500	addresses/km2) 300	(96.5) 2,574	(95.9)  
Numerical,	median	no.    
 No.	cows	in	2008    
  <1 35 35 0.44 
  1–2 26 26 0.65 
  >2 85 86 0.16 
 Nearest	bulk	tank	milk	positive	small-ruminant	farm	(meters) 9,793 11,301 0.01 
 Goat	density	(animals/km2)†    
  Within	5-km radius 9.2 6.7 0.27 
  Within	10-km radius 9.3 9.2 0.26 
 Sheep	density	(animals/km2)†    
  Within	5-km radius 30 33 0.04 
  Within	10-km radius 34 35 0.11 
 Cattle	density	(animals/km2)	within	5-km radius†    
  Including own animals 178 181 0.29 
  Excluding	own	animals 175 179 0.27 
 Cattle	density	(animals/km2)	within	10-km radius†    
  Including own animals 170 170 0.99 
  Excluding	own	animals 169 169 0.91 
*North	represents	Groningen,	Friesland,	and	Drenthe	Provinces;	East	represents	Gelderland,	Overijssel,	and	Flevoland	Provinces;	West	represents	
Noord–Holland,	Zuid–Holland,	Utrecht,	and	Zeeland	Provinces;	and	South	represents	Limburg	and	Noord–Brabant	Provinces. 
†Corrected for area in the Netherlands. 
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Univariate Analyses at Participant and Farm Levels
Risk factors for seropositivity for farmers/workers 
and residents included age >35 years; farm employment; 
directly performing cattle-related tasks; contact with cat-
tle, pigs, hay, cattle food, raw milk, manure, or cattle birth 
products; presence of rats or mice on the farm; and grow-
ing up on a farm (Table 3, Appendix). Protective factors 
included poultry and compost contact and fully compliant 
use of gloves during and around calving. Farm-based risk 
factors included a larger herd size, farm location in the 
southern region, an annual peak in calving, having beef 
cattle on the farm, and the presence of birds in the stable. 
Protective factors included automatic milking, having pet 
cats or rabbits, and having farm clothes and boots avail-
able for professional visitors (e.g., veterinarians and feed 
specialists) (Table 4). No relationship was found between 
PCR or ELISA status on the basis of BTM samples and 
participant seropositivity.
Multivariate and Multilevel Analyses
Of the 21 variables considered in the multivariate par-
ticipant model, 8 were independently associated with sero-
positivity: age >55 years; working on the farm; fully com-
pliant use of gloves during cattle birth care; contact with 
pigs, cattle at other farms, poultry, or compost; and indirect 
contact with rats or mice (Table 5). Interaction terms did 
not improve the model.
Of the 9 variables considered in the multilevel farm 
model, 6 were independently associated with seropositivity; 
larger herd size, farm location in the southern region, beef 
cattle on the farm, use of food concentrate, and presence of 
birds in the stable were risk factors, and automatic milking 
was a protective factor (Table 6). In the combined multilevel 
analysis, the 12 significant factors from the multivariate par-
ticipant and multilevel farm models, in addition to age, were 
combined in 1 model. The nonstratified model had a clearly 
better fit than the stratified model for farmers. Farm location 
within 8 km of the nearest C. burnetii–positive BTM small-
ruminant farm (odds ratio 2.3, 95% CI 1.2%–2.5%) was a 
risk factor in the final stratified multilevel model among 
farmers and was therefore included in the combined mul-
tilevel analysis. In the final overall model, independent risk 
factors were age >55 years, farm employment, pig contact, 
larger herd size, farm location in the southern region, beef 
cattle on the farm, cattle contact at other farms, and pres-
ence of birds in the stable. Indirect contact with rats or mice 
was borderline significant (Table 7). Protective factors were 
contact with poultry or compost, use of automatic milking, 
and fully compliant use of gloves during birth care. We ran 
an additional model by adding a protective variable (farm 
clothes and boots available for professional visitors), as de-
scribed in Table 5, in the farm-based and combined multi-
level models. Doing so resulted in a final model with the 
same factors as shown in Table 7, except that automatic 
milking was replaced by another protective factor (farm 
clothes and boots available for professional visitors) and 2 
borderline significant risk factors (distance to the nearest C. 
burnetii–positive BTM small-ruminant farm and use of by-
product feedstuffs) (data not shown).
Discussion
The overall seroprevalence of 72.1% among DCF 
residents, including employees, was high, indicating a con-
siderable lifetime risk for acquiring C. burnetii infection. 
Seroprevalence was highest among farmers (87.2%). The 
observed seroprevalence was similar to that determined by 
a study from the 1980s that showed an estimated serop-
revalence of 68.0% among 94 Dutch dairy farm residents; 
however, laboratory methods used in that study were dif-
ferent than those used by us (11). The 72.1% seropreva-
lence was also compatible with recent estimates among 
dairy goat farms residents (68.7%) (12), dairy sheep farms 
residents (66.7%) (13), and livestock veterinarians (65.1%) 
(14). Estimates for these livestock-associated groups 
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Table	2.	Participant	characteristics and Coxiella burnetii seroprevalence among	dairy	cattle	farm	residents,	the	Netherlands,	
September	2010– March	2011 
Participant	characteristic Total	no.	residents/no.	positive	(%) 95%	CI 
All participants 755/544	(72.1) 68.8–75.3 
Sex   
 M 431/368	(85.4) 82.0–88.7 
 F 323/176	(54.5) 49.0–59.9 
Age, y   
 <35 169/107	(63.3) 56.0–70.7 
 35–44 176/131	(74.4) 67.9–80.9 
 45–54 252/185	(73.4) 67.9–78.9 
 >55 132/106	(80.3) 73.4–87.2 
Role   
 Farmer 361/315	(87.2) 83.8–90.7 
 Spouse 222/121	(54.5) 47.9–61.1 
 Child	<18	y 52/23	(44.2) 30.3–58.2 
 Child	>18	y 54/40	(74.1) 62.0–86.1 
 Other* 40/30	(75.0) 61.0–89.0 
*Represents	other	family	members	and	employees. 
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exceed the seroprevalence of 2.4% for the Dutch popula-
tion during the pre-epidemic period, 2006–2007 (2), and 
the seroprevalences of 12.2% and 24.0% among persons 
residing in the most affected outbreak areas during the epi-
demic in the Netherlands (15,16).
Seroprevalence studies of other farmer populations, 
particularly dairy cattle farmers, are scarce, and, in gener-
al, it is difficult to compare international studies because 
of different study populations, tests, or cutoff values used. 
However, published seroprevalence estimates are generally 
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Table	4.	Univariate	logistic	model	of	farm-based characteristics associated with Coxiella burnetii positivity among dairy cattle farm 
residents,	the	Netherlands,	September	2010–March	2011* 
Variable No.	residents	total	(%	positive) OR	(95%	CI) 
No.	cows	on farm in 2008†‡ 755	(72.1) 1.0	(1.0–1.0) 
Nearest	bulk	tank milk positive small-ruminant farm†   
 <8	km 331	(75.8) 1.4	(1.0–1.9) 
 >8	km 424	(69.1) Reference 
Municipal	cattle	density,	including	beef	calves§ 755	(72.1) 1.0	(1.0–1.0) 
Farm location   
 Inside small-ruminant vaccination area 202	(78.2) 1.6	(1.0–2.3) 
 Outside small-ruminant vaccination area 553	(69.8) Reference 
Farm region†   
 South 170	(80.6) 1.8	(1.2–2.7) 
 Other  585	(69.6) Reference 
Beef cattle on the farm†   
 Yes 79	(82.3) 1.9	(1.1–3.4) 
 No 652	(70.7) Reference 
Annual peak in calving   
 Yes 135	(76.3) 1.3	(0.9–2.0) 
 No 601	(71.1) Reference 
Automatic milking†   
 Yes 154	(65.6) 0.7	(0.5–1.0) 
 No 580	(73.8) Reference 
Use of bedding in stables   
 Yes 717	(72.4) 1.9	(1.2–2.9) 
 No 19	(57.9) Reference 
Pet	cat   
 Yes 444	(69.1) 0.6	(0.	5–0.9) 
 No 285	(77.9) Reference 
Pet	rabbit   
 Yes 202	(64.4) 0.6	(0.4–0.8) 
 No 527	(75.7) Reference 
Birds in stable†   
 Yes 90	(82.2) 1.9	(1.0–3.6) 
 No 644	(70.5) Reference 
Use of by-product feedstuffs†   
 Yes 229	(77.3) 1.5	(1.0–2.1) 
 No 507	(69.6) Reference 
No. cows that calved in 2009‡ 720	(71.8) 1.0	(1.0–1.0) 
 No.	live-born calves   
  <78 335	(69.0) Reference 
  >78 344	(74.1) 1.3	(0.9–1.8) 
 No.	twin	calves   
  1–2 272	(69.9) Reference 
  >3 313	(76.4) 1.4	(1.0–2.0) 
Type of farm management†   
 Closed	herd 515	(73.4) Reference 
 Purchase	of	cattle 213	(68.1) 0.8	(0.6–1.1) 
No. cattle purchase addresses in 2007†   
 0	or	1 649	(72.7) Reference 
 >2 76	(64.5) 0.7	(0.4–1.0) 
Farm boots and work clothes available for professional visitors   
 Yes 662	(71.3) 0.7	(0.4–1.1) 
 No 74	(78.4) Reference 
Work clothes available for own personnel   
 Yes 556	(73.6) 1.4	(1.0–1.9) 
 No 180	(67.2) Reference 
*The analysis included the primary farm-based	factors	associated	with	positivity	(p<0.20	in	likelihood	ratio	test).	OR,	odds	ratio. 
†Variable included in later multivariate analysis before manual backward elimination. 
‡Risk increases per cow. 
§Risk	decreases	per	cow. 
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lower than what we observed. A study using IFA with 
the same cutoff value that we used estimated a seropreva-
lence of 27.0% among a UK farm cohort (385 residents/
workers) (17). Two other studies used a C. burnetii phase 
II IgG ELISA, which is somewhat less sensitive than 
IFA (9), and obtained seroprevalence estimates of 48.8% 
among Northern Ireland farmers from all types of farms 
(18) and 16.0% among 262 farm residents from 105 DCFs 
in Germany (19). A seroprevalence of 3.0% was observed 
in 163 residents from 100 farms (most likely cattle or pig) 
in Denmark; the study used the same IFA that we used, 
but cutoff values of IgG phase I and II were higher (≥512 
and >1,024, respectively) (20). Using the same cutoff, 
we would obtain a comparable seroprevalence estimate 
of 2.7%.
Farm residents living in the southern part of the Neth-
erlands were more likely to be seropositive. This was not 
surprising because living in the south was a risk factor for 
dairy goat farmers (12). In general, it is possible that sero-
positive DCF residents were partially affected by the many 
C. burnetii–positive BTM small-ruminant farms nearby. 
This possibility is supported by the close distance between 
residential addresses of persons who had a relatively recent 
infection and nearby C. burnetii–positive BTM small-ru-
minant farms. As determined on the basis of phase II IgM, 
1.2% of DCF residents and 11.0% of small-ruminant dairy 
farm residents had a relatively recent C. burnetii infection 
(12,13), indicating that the infection among DCF residents 
was generally in the more distant past. Physicians diagnosed 
Q fever in 0.5% of DCF residents in our study compared 
with 4.1% in Dutch goat farm residents (12); neverthe-
less, to ensure a timely diagnosis and treatment, physicians 
should consider Q fever in patients with compatible symp-
toms and occupational exposure to cattle (20,21). In gen-
eral, clinical illness from C. burnetii infection appears to 
be rare among DCF residents, which fits the suggestion in 
the literature that cattle-acquired C. burnetii infection has 
a milder clinical course (20). In other European countries 
and the United States, C. burnetii infection is endemic in 
cattle and in humans occupationally exposed to cattle, but 
there are few clinical cases of acute Q fever (22,23). A pos-
sible explanation is that abortion in late gestation is a key 
sign of infection in small dairy ruminants, but this is not 
the case in cattle. C. burnetii shedding by cattle is generally 
lower than that by small ruminants; concomitant and per-
sistent shedding patterns are more frequent in clinically af-
fected cows than healthy ones (24–29). Furthermore, sheep 
and goats have seasonal reproduction cycles and generally 
larger herd sizes, leading to huge amounts of bacteria shed 
during a short period. Multilocus variable-number tandem-
repeat analysis genotyping has indicated that C. burnetii 
genotypes in dairy cattle herds and dairy consumer prod-
ucts (30,31), except for 1 placenta sample, are clearly dis-
tinct from the predominant outbreak genotype found at 
Dutch small ruminant dairy farms in 2007–2009 (32). Up-
coming research should elucidate whether the cattle strains 
circulating in the Netherlands and other countries are 
less virulent.
Persons >55 years of age were at increased risk for se-
ropositivity, which cannot be explained by differences in 
specific cattle-related tasks, frequency of cattle contact, or 
hours worked. It may be that host factors or continuous or 
regular exposure to the bacterium (booster effect) play a 
role that cannot adequately be assessed through a question-
naire. Full-time farm employment (>40 h/week) was a risk 
factor, which corresponds with a study among Dutch live-
stock veterinarians in which >30 hours of weekly animal 
contact was a risk factor for infection (14). Full-time farm 
employment and working or residing on a dairy (primarily) 
farm were risk factors in a UK farm cohort (17), indicating 
a dose-response relationship between seropositivity and the 
number of working hours spent with dairy cattle or in a 
dairy farm environment in general.
We identified several cattle-related risk factors for sero-
positivity among cattle farm residents/staff: herd size, cattle 
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Table	5.	Multivariate	logistic	regression	analysis	of	participant-
based characteristics associated with Coxiella burnetii positivity 
among	dairy	cattle	farm	residents,	the	Netherlands,	September	
2010–March	2011* 
Association with positivity, characteristic OR	(95%	CI) 
Positive	association  
 Age, y  
  <35 Reference 
  35–44 1.4	(0.8–2.3) 
  45–54 1.0	(0.6–1.6) 
  >55 1.9	(1.0–3.5) 
 Work on farm  
  No Reference 
  Part	time	(1–39	h/wk) 2.4	(1.1–5.2) 
  Full	time	(>40	h/wk) 10.4	(4.2–25.7) 
 Contact	with	pigs	at	own	or	other	farm  
  Yes 2.6	(1.2–5.4) 
  No Reference 
 Contact	with	cows	at	other	farm  
  Yes 1.6	(1.0–2.6) 
  No Reference 
 Indirect	contact	with	rats/mice	at	own	farm  
  Yes 1.5	(1.0–2.4) 
  No Reference 
Negative	association  
 Use of gloves during cattle birth care  
  Fully compliant 0.4	(0.2–0.8) 
  Partly	or	noncompliant Reference 
  No	birth	care 0.7	(0.4–1.1) 
 Contact	with	poultry	at	own	farm  
  Yes 0.6	(0.4–0.9) 
  No Reference 
 Contact	with	compost  
  Yes 0.6	(0.3–0.9) 
  No Reference 
*The analysis included the primary participant-based characteristics 
associated	with	positivity	(p<0.10	in	likelihood	ratio	test).	The	number	of	
observations	was	712.	Model	fit	was	assessed	by	use	of	the	Hosmer–
Lemeshow	goodness-of-fit	test	(p	=	0.91).	OR,	odds	ratio. 
 
C. burnetii	Risk	for	Humans	on	Dairy	Cattle	Farms
contact at other farms, and presence of beef cattle on their 
own farm. A larger herd size could pose a risk because of an 
increased chance for C. burnetii introduction or the presence 
of a larger susceptible population of cows; however, some 
farm-based risk factors associated with a large herd that 
were not assessed through the questionnaire might also have 
caused this effect (19,33,34). Cattle contact at other farms 
possibly reflects risk from exposure to C. burnetii in other 
infected herds. The presence of beef cattle as a risk factor for 
DCF residents is not easily explained, but it might reflect risk 
from more intense birth care and, therefore, more extensive 
human contact with cattle and birth products.
Protective factors included use of automatic milking 
and fully compliant use of gloves during birth care. Birth 
products of C. burnetii–infected ruminants are a source 
of human infections. A German study among veterinar-
ians identified an association between increasing numbers 
of cattle obstetric procedures performed and seropositiv-
ity (21). Pig contact, indirect contact with rats/mice, and 
presence of wild or domesticated birds in the stable were 
indicated as risk factors in our study. Studies among veteri-
narians in the Netherlands and the United States identified 
swine contact as a risk factor (14,35); however, C. burnetii 
has not been found in pigs in the Netherlands (30). Rats 
and wild birds were identified as C. burnetii reservoirs in 
several studies (36–38) and as reservoirs on cattle farms in 
the Netherlands (39).
Fully compliant use of gloves during birth care can 
help farmers protect themselves against C. burnetii in-
fection (21). Consistent use of farm boots and working 
clothes for professional visitors was a protective factor 
in our additional multilevel model. It might appear that 
the use of protective clothing by visitors will prevent C. 
burnetii transmission to the visitor rather than the farmer; 
however, providing gloves and farm clothes for visitors 
indicates a state of optimal awareness on the farm with 
regard to communicable diseases. In addition, automatic 
milking of cows might reflect less direct cattle exposure, 
especially through avoiding contact with the udders, raw 
milk, manure, and genital fluids, and thus might limit the 
chance of infection. Statistical analyses indicated lower 
risk for seropositivity among farm residents exposed to 
poultry and to compost. We have no biologically plau-
sible explanation for this finding, and the statistical ef-
fect might have occurred by chance. Raw milk consump-
tion was a risk factor for seropositivity in German dairy 
cattle farmers (19). Although consumption of raw milk 
was not an independent risk factor in our study, 21.8% 
of farm residents reported daily drinking of raw milk. 
C. burnetii exposure during nonautomatic milking could 
still implicate the risk of inhaling contaminated aerosols 
during pretreatment of the cow or during accidental raw 
milk ingestion.
The relatively low response rate of 10.4% in this study 
can be explained by a general lack of motivation or aware-
ness among cattle farmers because Q fever was mainly con-
sidered a problem among small-ruminant dairy farms. A 
general fear of consequences resulting from possible con-
trol measures targeting the cattle sector comparable with 
implemented control measures for Q fever in the small-ru-
minant sector might also have played a role. Study results 
are, however, considered representative for the Dutch dairy 
cattle sector because participating and nonparticipating 
farms were generally comparable.
The overall C. burnetii seroprevalence of 72.1% 
among DCF residents is high. Multilevel analysis identi-
fied several plausible risk factors (e.g., employment on a 
farm, larger herd size, and cattle contact at other farms). 
A farm location in the southern region as risk factor sug-
gests C. burnetii transmission from small-ruminant dairy 
farms to cattle farm residents living nearby. Use of au-
tomatic milking and fully compliant use of gloves dur-
ing birth care are plausible protective factors, indicating 
less direct contact with cattle and, thus, a reduced chance 
of animal-to-human transmission. The dairy cattle sector 
must inform farmers about potential sources of infection. 
Biosecurity measures are warranted; for example, wild 
birds and vermin should be kept out of stables, and farm-
ers/staff should be educated regarding the consistent use 
of PPE, such as wearing gloves during birth assistance 
and invasive procedures. Physicians should consider Q 
fever in the differential diagnosis for dairy cattle farmers 
with compatible symptoms. Future studies should more 
explicitly assess the clinical effect of acute and chronic Q 
fever in humans who live or work on DCFs.
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Table	6.	Multilevel	analysis	of	farm-based characteristics as 
independent factors associated with Coxiella burnetii positivity 
among	dairy	cattle	farm	residents,	the	Netherlands,	September	
2010–March	2011* 
Variable OR	(95%	CI) 
No. cows on farm in 2008† 1.0	(1.0–1.0) 
Farm region  
 South 1.8	(1.2–2.8) 
 Other Reference 
Beef cattle on farm  
 Yes 1.7 (1.0–2.8) 
 No Reference 
Automatic milking  
 Yes 0.7	(0.4–1.0) 
 No Reference 
Birds in stable  
 Yes 2.0	(1.1–3.8) 
 No Reference 
Use of by-product feedstuffs  
 Yes 1.4	(1.0–2.0) 
 No Reference 
*The analysis included the primary farm-based characteristics associated 
with	positivity	(p<0.10	in	likelihood	ratio	test).	The	number	of	observations	
was	716;	the	number	of	levels	used	was	309	(quasi-likelihood under the 
independence	model	criterion	832.88).	OR,	odds	ratio. 
†Risk increased per cow. 
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